Semaglutide Workbook: Supporting Your Journey with GLP-1 Agonist - Track Nutrition, Diet, Calories, Hunger Cues, Macros, and Hydration
The pharma partners backed their application for Dupixent in COPD with data from a pair of Phase III trials, in which treatment with the injection elicited a 30% and 34% reduction in the annualized rate of moderate or severe COPD exacerbations compared to placebo
This would unlock a new generation of peptide drugs that are both potent and easy to deliver
It downregulates the gene and protein expression of COX1, 5-LOX, 12-LOX, and 15-LOX in the arachidonic acid pathway, restores the levels of abnormal metabolites such as PGE2, PGD2, LTB4, 12-HETE, 15-HETE, PGF2, and 8-iso-PGF2 in PAH models, inhibits abnormal proliferation of PASMCs, and reverses pulmonary vascular remodeling (Song et al., 2022)
discussed the FDAs actions against the peptides with podcaster Joe Rogan in February